In addition, we separately analyzed the relationship between KRT17 expression and prognosis in the various molecular subtypes of BC, especially those with different HER2 and ER profiles according to patients’ survival analysis (Supplementary Figure S2A–C). This evidence concerns the gene ERBB2 and breast cancer.